GLAXF   $16.63  -18.93% Market Closed

GlaxoSmithKline PLC
Last Events:

2022-08-18 Trend pattern changed from расходящийся клин с наклоном вверх to сужающийся канал.

2022-08-18 Signal in Stochastic changed from bullish recovery to bearish. The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

2022-08-18 Signal in MACD changed from bullish to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: entry into the oversold zone.

2022-08-18 Signal in RSI changed from bullish recovery to bearish recovery. RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

2022-08-18 Signal in EMA100 changed from bullish reversal to bearish reversal. 2022-07-12 the price crossed down the moving average line and formed a short-term downside trend.

2022-08-18 Signal in EMA50 changed from bullish reversal to bearish reversal. 2022-07-08 the price crossed down the moving average line and formed a short-term downside trend.

2022-08-18 Signal in EMA20 changed from bullish reversal to bearish reversal. 2022-07-08 the price crossed down the moving average line and formed a short-term downside trend.

2022-08-18 Trend Power changed from strong to slow.


Current temperature: 13.01
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi ActivelyBuy - -
macd Sell Sell -
stoch Sell - -
ma20 Sell - -
ma50 Sell - -
ma100 Sell - -
Candlestick PatternMarch 8, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN GB0009252882
ceo Ms. Sally Jackson
Website https://www.gsk.com
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.